Financhill
Sell
48

NHS Quote, Financials, Valuation and Earnings

Last price:
$7.24
Seasonality move :
3.5%
Day range:
$7.23 - $7.28
52-week range:
$6.62 - $7.94
Dividend yield:
14.98%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
126.7K
Avg. volume:
162K
1-year change:
-7.88%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Period Ending 2016-10-31 2017-10-31 2018-10-31 2019-10-31 2020-10-31
Revenue $29.2M $25.8M -$834.8K $25.5M $6.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $787.1K $720.7K $661.3K $1.2M $1.4M
Other Inc / (Exp) -$16.4M $8.5M $1.9M -$9.5M -$12.4M
Operating Expenses $814.6K $697.3K $691.7K $1.2M $1.4M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $28.4M $25.1M -$1.5M $24.3M $4.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $27.4M $23.9M -$3.1M $22.5M $3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $28.4M $25.1M -$1.5M $24.3M $4.6M
 
Basic EPS (Cont. Ops) $1.40 $1.22 -$0.16 $1.16 $0.16
Diluted EPS (Cont. Ops) $1.40 $1.22 -$0.16 $1.16 $0.16
Weighted Average Basic Share $19.5M $19.6M $19.3M $19.4M $18.9M
Weighted Average Diluted Share $19.5M $19.6M $19.3M $19.4M $18.9M
 
EBITDA -- -- -- -- --
EBIT $30.1M $27.3M $1.4M $27.7M $6.7M
 
Revenue (Reported) $29.2M $25.8M -$834.8K $25.5M $6.1M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $30.1M $27.3M $1.4M $27.7M $6.7M
Period Ending 2021-12-08 2022-12-08 2023-12-08 2024-12-08
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2021-12-08 2022-12-08 2023-12-08 2024-12-08
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2014-12-08 2015-12-08 2016-12-08 2017-12-08 2018-12-08
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2016-10-31 2017-10-31 2018-10-31 2019-10-31 2020-10-31
Cash and Equivalents $843.4K $113.7K $16.7K $753.3K $21.7K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $171.6K $17.2K $17.5K $18.6K $20.6K
Other Current Assets -- -- -- -- --
Total Current Assets $8.7M $8.1M $9.3M $11.8M $5.8M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments $376.5M $386.2M $368.7M $371.5M $353.6M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $386M $394.3M $378M $383.3M $360.1M
 
Accounts Payable $4.5M $6.2M $7.6M $10.2M $2M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.5M $6.2M $7.7M $10.3M $2.5M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $129.6M $131.8M $134.7M $135.8M $130.7M
 
Common Stock $279.8M $275M $274.3M $272M $265.7M
Other Common Equity Adj -- -- -- -- --
Common Equity $256.4M $262.5M $243.3M $247.5M $229.3M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $256.4M $262.5M $243.3M $247.5M $229.3M
 
Total Liabilities and Equity $386M $394.3M $378M $383.3M $360.1M
Cash and Short Terms $843.4K $113.7K $16.7K $753.3K $21.7K
Total Debt -- -- -- -- --
Period Ending 2017-04-30 2018-04-30 2019-04-30 2020-04-30 2021-04-30
Cash and Equivalents -- $137.4K -- $653.8K $2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- $7.9K --
Other Current Assets -- -- -- -- --
Total Current Assets $11.7M $10.5M $9.4M $10.9M $7M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments $381.1M $369.9M $372.9M $326.1M $283.3M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $393.4M $380.4M $382.3M $337.8M $290.6M
 
Accounts Payable $5.4M $3.7M $5.5M $5.3M $4.5M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $5.4M $3.7M $5.6M $5.7M $4.7M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $130.4M $130.7M $131.5M $135.7M $104.7M
 
Common Stock $279.8M $275M $274.3M $272M $207M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $263M $249.7M $250.8M $202.1M $185.9M
 
Total Liabilities and Equity $393.4M $380.4M $382.3M $337.8M $290.6M
Cash and Short Terms -- $137.4K -- $653.8K $2M
Total Debt -- -- -- -- --
Period Ending 2016-10-31 2017-10-31 2018-10-31 2019-10-31 2020-10-31
Net Income to Stockholders $27.4M $23.9M -$3.1M $22.5M $3M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $2.4M $217.7K $96.3K -$3.9M $5.3M
Change in Inventories -- -- -- -- --
Cash From Operations $19.5M $17M $16M $21M $21.2M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -$18.8M -$17.7M -$16.1M -$18.3M -$21.2M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- -$95M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$18.8M -$17.7M -$16.1M -$18.3M -$21.2M
 
Beginning Cash (CF) $104.8K $843.4K $113.7K -$2M $667.7K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $738.6K -$729.7K -$97.1K $2.6M -$58.7K
Ending Cash (CF) $843.4K $113.7K $16.7K $667.7K $609.1K
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-12-08 2022-12-08 2023-12-08 2024-12-08
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-12-08 2022-12-08 2023-12-08 2024-12-08
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2014-12-08 2015-12-08 2016-12-08 2017-12-08 2018-12-08
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock